ASH News Daily - Monday, December 12, 2011 - (Page B-32)

ZOMETA should not be used during preg to avoid becoming pregnant. If the patie this drug, the patient should be apprised In postmarketing experience, severe an has been reported in patients taking bis Thank you to the following companies that provide educational support for symptoms develop, and a subset of pa the 2011 ASH Annual Meeting: the same2011.) or another bisphosphon (These acknowledgments reflect contributions made prior to October 4, drug sensitive patients receiving bisphosphon Insufficient data exist on how to safely u Acute-phase reaction symptoms can o with ZOMETA vs. 33% with pamidron chills, flushing, bone pain and/or arthralg clinical trials, regardless of causality, wit constipation (27%), anemia (22%), dy cancer Program on DVD Hematology 2011 (the Education Program Book) and the Education (16%), insomnia (15%), vomiting (13%), confusion (13%), agitation (13 pain (12%), hypotension (11%), and hy (5-10% frequency) occurring in greater leg edema, mucositis, dysphagia, gra hypocalcemia, dehydration, arthralgias, h been infrequently reported. The most common adverse events (≥15 4 mg (n=1031) were as follows: bone vomiting (32%), constipation (31%), dy ASH Abstracts on Flash Drive and Internet Program Planner (22%), cough (22%), arthralgia (21%), l (19%), dizziness (excluding vertigo) (18% (15%). Patients should also be made aw Ocular adverse events may occur with orporAte riendS conjunctivitis, iritis, and orbital inflamma some cases, symptoms resolved with t ASH is grateful for the support it receives throughout the year from the following companies: Caution is advised when bisphosphonat and potentially nephrotoxic drugs. Patients with multiple myeloma and bo supplement of 500 mg and a multiple v 2011 ASH Annual Meeting ASH C F References: 1. Rosen LS, Gordon D, Kaminski M, et al; Z compared with pamidronate disodium in the treatment o blind, multicenter, comparative trial. Cancer. 2003;98:1 patterns associated with early vs. delayed zoledronic ac et al. Review of 1027 patients with newly diagnosed mu Please see full Prescribing Information. Please see brief summary of full Prescribin © 2011 Novartis

Table of Contents for the Digital Edition of ASH News Daily - Monday, December 12, 2011

ASH News Daily - Monday, December 12, 2011

https://www.nxtbookmedia.com